Cattle tick vaccines: Many candidate antigens, but will a commercially viable product emerge?

International Journal for Parasitology

Volumn 42, Issue 5, 2012, Pages 421-427

  Guerrero, Felix D ^a   Miller, Robert J ^b   Pérez de León, Adalberto A ^a  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b USDA ARS Cattle Fever Tick Research Laboratory   (United States)

Author keywords

Cattle tick; Protective antigen; Recombinant protein; Tick control; Vaccine

Indexed keywords

ANTIGEN 2; BM86 ANTIGEN VACCINE; CATTLE TICK VACCINE; DNA VACCINE; FERRITIN 2; GAVAC; HAEMAPHYSALIS LONGICORNIS RECOMBINANT GLUTATHIONE TRANSFERASE; PEPTIDE VACCINE; PEPTIDE VACCINE SBM7462; TICKGARD; UNCLASSIFIED DRUG; VACCINE;

ANTIGEN; CATTLE; CHEMICAL CONTROL; PESTICIDE APPLICATION; PROTEIN; RECOMBINATION; TICK; VACCINE;

ARTICLE; CATTLE; CATTLE FARMING; CONSUMER ATTITUDE; DRUG EFFICACY; DRUG MARKETING; DRUG SCREENING; IMMUNOGENICITY; INSECT CONTROL; NONHUMAN; PRODUCT SAFETY; RHIPICEPHALUS (BOOPHILUS) MICROPLUS; TICK INFESTATION; VACCINATION;

ANIMALS; ANTIGENS; ARTHROPOD PROTEINS; CATTLE; CATTLE DISEASES; RHIPICEPHALUS; TICK INFESTATIONS; VACCINES;

BOOPHILUS MICROPLUS; BOS; IXODIDA; RHIPICEPHALUS;

EID: 84861226739     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.04.003     Document Type: Article

References (49)

1. Aldrich, L., Blisard, N., 1998. Consumer acceptance of biotechnology. Lessons from the rbST experience. Current Issues in Economics of Food Markets, Agriculture Information Bulletin No. 747-01. Economic Research Service, United States Department of Agriculture.
2. Almazan C., Lagunes R., Villar M., Canales M., Rosario-Cruz R., Jongejan F., de la Fuente J. Identification and characterization of Rhipicephalus (Boophilus) microplus candidate protective antigens for the control of cattle tick infestations. Parasitol. Res. 2010, 106:471-479.
3. Almazan C., Moreno-Cantu O., Moreno-Cid J.A., Galindo R.C., Canales M., Villar M., de la Fuente J. Control of tick infestations in cattle vaccinated with bacterial membranes containing surface-exposed tick protective antigens. Vaccine 2012, 30:265-272.
4. Andreotti R., Guerrero F.D., Soares M.A., Barros J.C., Miller R.J., Perez de Leon A. Rhipicephalus (Boophilus) microplus acaricide resistance in the Brazilian state of Mato Grosso do Sul. Rev. Bras. Parasitol. 2011, 20:127-133.
5. Barnard A.-C., Nijhof A.M., Gaspar A.R.M., Neitz A.W.H., Jongejan F., Maritz-Olivier C. Expression profiling, gene silencing and transcriptional networking of metzincin metalloproteases in the cattle tick, Rhipicephalus (Boophilus) microplus. Vet. Parasitol. 2011, 186:403-414.
6. Bellgard M., Moolhuijzen P.M., Guerrero F.D., Schibeci D., Rodriguez-Valle M., Peterson D.G., Dowd S.E., Barrero R., Hunter A., Miller R.J., Lew-Tabor A.E. CattleTickBase: an integrated Internet-based bioinformatics resource for Rhipicephalus (Boophilus) microplus. Int. J. Parasitol. 2012, 42:161-169.
7. Brake D.K., Pérez de León A.A. Immunoregulation of bovine macrophages by factors in the salivary glands of Rhipicephalus microplus. Parasites Vect. 2012, 5:38.
8. Canales M., Almazan C., Naranjo V., Jongejan F., de la Fuente J. Vaccination with recombinant Boophilus annulatus Bm86 ortholog protein, Ba86, protects cattle against B. annulatus and B. microplus infestations. BMC Biotechnol. 2009, 9:29.
9. Canales M., Enriquez A., Ramos E., Cabrera D., Dandie H., Soto A., Falcon V., Rodriguez M., de la Fuente J. Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick. Vaccine 1997, 15:414-422.
10. de Castro J.J. Sustainable tick and tickborne disease control in livestock improvement in developing countries. Vet. Parasitol. 1997, 71:77-97.
11. de la Fuente J., Almazan C., Perez de la Lastra J.M., Kocan K.M., Willadsen P. A ten-year review of commercial vaccine performance for control of tick infestations on cattle. Anim. Health Res. Rev. 2007, 8:23-28.
12. Dryden M.W., Payne P.A. Biology and control of ticks infesting dogs and cats in North America. Vet. Ther. 2004, 5:139-154.
13. Ehreth J. The global value of vaccination. Vaccine 2003, 21:596-600.
14. Fellay J., Frahm N., Shianna K.V., Cirulli E.T., Casimiro D.R., Robertson M.N., Haynes B.F., Geraghty D.E., McElrath M.J., Goldstein D.B. Host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the Step Trial. J. Infect. Dis. 2011, 203:773-779. for the National Institute of Allergy and Infectious Diseases (NIAID) Center for HIV/AIDS Vaccine Immunology (CHAVI) and the NIAID HIV Vaccine Trials Network (HVTN).
15. Fragoso H., Hoshman Rad P., Ortiz M., Rodriguez M., Redondo M., Herrera L., de la Fuente J. Protection against Boophilus annulatus infestations in cattle vaccinated with the B. microplus Bm86-containing vaccine Gavac. Vaccine 1998, 16:1990-1992.
16. Graf J.-F., Gogolewski R., Leach-Bing N., Sabatini G.A., Molento M.B., Bordin E.L., Arantes G.J. Tick control: an industry point of view. Parasitol. 2004, 129:S427-S442.
17. Graham O.H., Hourrigan J.L. Eradication programs for the arthropod parasites of livestock. J. Med. Entomol. 1977, 13:629-658.
18. Grisi L., Massard C.L., Moya Borja G.E., Pereira J.B. Impacto economico das principais ectoparasitoses em bovinos no Brasil. Hora Vet. 2002, 125:8-10.
19. Hajdusek O., Sojka D., Kopacek P., Buresova V., Franta Z., Sauman I., Winzerling J., Grubhoffer L. Knockdown of proteins involved in iron metabolism limits tick reproduction and development. Proc. Natl. Acad. Sci. USA 2009, 106:1033-1038.
20. Hajdusek O., Almazan C., Loosova G., Villar M., Canales M., Grubhoffer L., Kopacek P., de la Fuente J. Characterization of ferritin 2 for the control of tick infestations. Vaccine 2010, 28:2993-2998.
21. Heldens J.G.M., Patel J.R., Chanter N., ten Thij G.J., Gravenkijck R., Schijns V.E.J.C., Langen A., Schetters Th.P.M. Veterinary vaccine development from an industrial perspective. Veter. J. 2008, 178:7-20.
22. Leal A.T., Seixas A., Pohl P.C., Ferreira C.A.S., Logullo C., Oliveira P.L., Farias S.E., Termignoni C., da Silva Vaz I., Masuda A. Vaccination of bovines with recombinant Boophilus yolk pro-cathepsin. Vet. Immunol. Immunopathol. 2006, 114:341-345.
23. Lodos J., Ochagavia M.E., Rodriguez M., de la Fuente J. A simulation study of the effects of acaricides and vaccination on Boophilus cattle-tick populations. Prev. Vet. Med. 1999, 38:47-63.
24. McKee A.S., MacLeod M.K.L., Kappler J.W., Marrack P. Immune mechanisms of protection: can adjuvants rise to the challenge?. BMC Biol. 2010, 8:37.
25. Nichani A.K., Mena A., Popowych Y., Dent D., Townsend H.G.G., Mutwiri G.K., Hecker R., Babiuk L.A., Griebel P.J. In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. Vet. Immunol. Immunopathol. 2004, 98:17-29.
26. Nuttall P.A., Trimnell A.R., Kazimirova M., Labuda M. Exposed and concealed antigens as vaccine targets for controlling ticks and tick-borne diseases. Parasite Immunol. 2006, 28:155-163.
27. Oberg A.L., Kennedy R.B., Li P., Ovsyannikova I.G., Poland G.A. Systems biology approaches to new vaccine development. Curr. Opin. Immunol. 2011, 23:436-443.
28. Parizi L.F., Pohl P.C., Masuda A., da Silva Vaz I. New approaches toward anti-Rhipicephalus (Boophilus) microplus tick vaccine. Rev. Bras. Parasitol. Vet. Jaboticabal 2009, 18:1-7.
29. Parizi L.F., Utiumi K.U., Imamura S., Onuma M., Ohashi K., Masuda A., da Silva Vaz I. Cross immunity with Haemaphysalis longicornis glutathione S-transferase reduces an experimental Rhipicephalus (Boophilus) microplus infestation. Exp. Parasitol. 2011, 127:113-118.
30. Patarroyo J.H., Portela R.W., De Castro R.O., Pimentel J.C., Guzman F., Patarroyo M.E., Vargas M.I., Prates A.A., Dias Mendes M.A. Immunization of cattle with synthetic peptides derived from the Boophilus microplus gut protein (Bm86). Vet. Immunol. Immunopathol. 2002, 88:163-172.
31. Patarroyo J.H., Vargas M.I., Gonzalez C.Z., Guzman F., Martins-Filho O.A., Afonso L.C.C., Valente F.L., Peconick A.P., Marciano A.P., Patarroyo A.M., Sossai S. Immune response of bovines stimulated by synthetic vaccine SBm7462® against Rhipicephalus (Boophilus) microplus. Vet. Parasitol. 2009, 166:333-339.
32. Peconick A.P., Sossai S., Girao F.A., Rodrigues M.Q.R.B., Souza e Silva C.H., Guzman F., Patarroyo A.M., Vargas M.I., Patarroyo J.H. Synthetic vaccine (SBm7462) against cattle tick Rhipicephalus (Boophilus) microplus: preservation of immunogenic determinants in different strains from South America. Exp. Parasitol. 2008, 119:37-43.
33. Perez-Cogollo L.C., Rodriguez-Vivas R.I., Ramirez-Cruz G.T., Miller R.J. First report of the cattle tick Rhipicephalus microplus resistant to ivermectin in Mexico. Vet. Parasitol. 2010, 168:165-169.
34. Playford, M., 2005. Review of Research Needs for Cattle Tick Control, Phases I and II, Meat & Livestock Australia Limited, North Sydney, ISBN 1 74036 685 9.
35. Prudencio C.R., Marra A.O.M., Cardoso R., Goulart L.R. Recombinant peptides as new immunogens for the control of the bovine tick, Rhipicephalus (Boophilus) microplus. Vet. Parasitol. 2010, 172:122-131.
36. Pruett J.H., Barrett C.C., Fisher W.F. Kinetic development of serum antibody to purified Hypoderma lineatum proteins in vaccinated and nonvaccinated cattle. Southwestern Entomol. 1987, 12:79-88.
37. Rachinsky A., Guerrero F.D., Scoles G.A. Proteomic profiling of Rhipicephalus (Boophilus) microplus midgut responses to infection with Babesia bovis. Vet. Parasitol. 2008, 152:294-313.
38. Rodríguez-Vivas R.I., Rivas A.L., Chowell G., Fragoso S.H., Rosario C.R., García Z., Smith S.D., Williams J.J., Schwager S.J. Spatial distribution of acaricide profiles (Boophilus microplus strains susceptible or resistant to acaricides) in southeastern Mexico. Vet. Parasitol. 2007, 146:158-169.
39. Sales-Junior P.A., Guzman F., Varga M.I., Sossai S., Patarroyo A.M., Gonzalez C.Z.L., Patarroyo J.H. Use of biodegradable PLGA microspheres as a slow release delivery system for the Boophilus microplus synthetic vaccine SBm7462. Vet. Immunol. Immunopath. 2005, 107:281-290.
40. Sitte K., Brinkworth R., East I.J., Jazwinska E.C. A single amino acid deletion in the antigen binding site of BoLA-DRB3 is predicted to affect peptide binding. Vet. Immunol. Immunopathol. 2002, 85:129-135.
41. Sloat B.R., Sandoval M.A., Hau A.M., He Y., Cui Z. Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles. J. Controlled Release 2010, 141:93-100.
42. Trimnell A.R., Hails R.S., Nuttall P.A. Dual-action ectoparasite vaccine targeting "exposed" and "concealed" antigens. Vaccine 2002, 20:3560-3568.
43. Turni C., Lee R.P., Jackson L.A. The effects of salivary gland extracts from Boophilus microplus ticks on mitogen-stimulated bovine lymphocytes. Vet. Res. Comm. 2007, 31:545-552.
44. plus vaccine against Rhipicephalus (Boophilus) microplus induce similar reproductive suppression to three initial vaccinations under production conditions. BMC Vet. Res. 2010, 6:43.
45. Willadsen P. Anti-tick vaccines. Ticks: Biology, Disease and Control 2008, 424-446. Cambridge University Press, Cambridge. A.S. Bowman, P.A. Nuttall (Eds.).
46. Willadsen P., Bird P., Cobon G.S., Hungerford J. Commercialisation of a recombinant vaccine against Boophilus microplus. Parasitology 1995, 110:S43-S50.
47. Willadsen P., Smith P., Cobon G., McKenna R.V. Comparative vaccination of cattle against Boophilus microplus with recombinant antigen Bm86 alone or in combination with recombinant Bm91. Parasite Immunol. 1996, 18:241-246.
48. Yue H., Wei W., Fan B., Yue Z., Wang L., Ma G., Su Z. The orchestration of cellular and humoral responses is facilitated by divergent intracellular antigen trafficking in nanoparticle-based therapeutic vaccine. Pharmacol. Res. 2012, 65:189-197.
49. Zivkovic Z., Torina A., Mitra R., Alongi A., Scimeca S., Kocan K.M., Galindo R.C., Almazan C., Blouin E.F., Villar M., Nijhof A.M., Mani R., La Barbera G., Caracappa S., Jongejan F. Subolesin expression in response to pathogen infection in ticks. BMC Immunol. 2010, 11:7.